Journal article
Combined chemotherapy and radiation therapy for non-small-cell lung cancer.
Abstract
In a previous study of patients with recurrent or disseminated non-small-cell lung cancer (NSCLC), the combination of bleomycin, etoposide, and cisplatin (BEP) produced objective responses in ten of 17 (59%) patients with large-cell anaplastic carcinoma and in 14 of 35 (40%) with squamous-cell carcinoma. These results prompted a pilot study of combined modality therapy in which two cycles of BEP were administered prior to split-course radiation …
Authors
Osoba D; Rusthoven JJ; Evans WK; Turnbull KA
Journal
Seminars in Oncology, Vol. 13, No. 3 Suppl 3, pp. 121–124
Publication Date
September 1986
ISSN
0093-7754